Drug Erlotinib

Swiss pharma major F Hoffmann-La Roche and India's Glenmark Pharmaceuticals have settled out of court a patent litigation over the former's lung cancer drug erlotinib hydrochloride sold under the brand name 'Tarceva'.

It was just a tiny bump behind Corey Wood's right eye, but her doctor was concerned. The college senior and marathon runner felt fine, but a full-body scan revealed that she had Stage 4 lung cancer.

Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La Roche's patent on lung cancer drug erlotinib hydrochloride.

Swiss pharma major F Hoffmann-La Roche and India's Glenmark Pharmaceuticals have settled out of court a patent litigation over the former's lung cancer drug erlotinib hydrochloride sold under the brand name 'Tarceva'.

It was just a tiny bump behind Corey Wood's right eye, but her doctor was concerned. The college senior and marathon runner felt fine, but a full-body scan revealed that she had Stage 4 lung cancer.

Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La Roche's patent on lung cancer drug erlotinib hydrochloride.